CSIMarket
 


Lifeloc Technologies Inc   (LCTC)
Other Ticker:  
 
 

LCTC's Revenue Growth by Quarter and Year

Lifeloc Technologies Inc 's Revenue results by quarter and year




LCTC Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter December - 2.19 2.11 1.63
III Quarter September - 2.70 2.03 1.89
II Quarter June - 2.28 2.18 1.73
I Quarter March 2.15 2.16 2.16 1.81
FY   2.15 9.33 8.48 7.06



LCTC Revenue first quarter 2024 Y/Y Growth Comment
Lifeloc Technologies Inc reported decrease in Revenue in the first quarter 2024 by -0.3% to $ 2.15 millions, from the same quarter in 2023.
The decrease in the first quarter 2024 Lifeloc Technologies Inc 's Revenue compares unfavorably to the Company's average Revenue growth of 2.92%.

Looking into first quarter 2024 results within Laboratory Analytical Instruments industry 9 other companies have achieved higher Revenue growth. While Lifeloc Technologies Inc ' s Revenue decline of -0.3% ranks overall at the positon no. 1391 in the first quarter 2024.




LCTC Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter December - 3.79 % 29.45 % 11.64 %
III Quarter September - 33 % 7.41 % 21.15 %
II Quarter June - 4.59 % 26.01 % 31.06 %
I Quarter March -0.3 % 0 % 19.34 % -10.4 %
FY   - 10.02 % 20.11 % 11.01 %

Financial Statements
Lifeloc Technologies Inc 's first quarter 2024 Revenue $ 2.15 millions LCTC's Income Statement
Lifeloc Technologies Inc 's first quarter 2023 Revenue $ 2.16 millions Quarterly LCTC's Income Statement


LCTC Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter December - -18.89 % 3.94 % -13.76 %
III Quarter September - 18.42 % -6.88 % 9.25 %
II Quarter June - 5.56 % 0.93 % -4.42 %
I Quarter March -1.67 % 2.37 % 32.52 % 23.97 %
FY (Year on Year)   - 10.02 % 20.11 % 11.01 %




Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #10
Healthcare Sector #220
Overall #1391

Revenue Y/Y Growth Statistics
High Average Low
23.86 % 2.92 % -29.35 %
(March 31, 2014)   (Mar 31 2021)
Revenue first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #10
Healthcare Sector #220
Overall #1391
Revenue Y/Y Growth Statistics
High Average Low
23.86 % 2.92 % -29.35 %
(March 31, 2014)   (Mar 31 2021)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Lifeloc Technologies Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
32.74 % 1.07 % -34.6 %
(Mar 31 2022)  


LCTC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Lifeloc Technologies Inc reported decrease in Revenue from the previous quarter by -1.67% to $ 2.15 millions, from $ 2.19 millions declared in the previous quarter.

Although cyclical influence usually energize I. Quarter 2024 results, it clearly was not enough to salvage Lifeloc Technologies Inc 's I. Quarter 2024 achievement, Most analysts wrote and mentioned that average quarter on quarter Revenue growth is at 1.07% for LCTC.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Lifeloc Technologies Inc 's Revenue growth quarter on quarter, overall rank is 1921.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #5
Healthcare Sector #270
Overall #1921
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #5
Healthcare Sector #270
Overall #1921
Revenue Q/Q Growth Statistics
High Average Low
32.74 % 1.07 % -34.6 %
(Mar 31 2022)  


LCTC's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2024 Lifeloc Technologies Inc reported decrease in Revenue from the previous quarter by -1.67% to $ 2.15 millions, from $ 2.19 millions released in the previous quarter.

Although cyclical factors usually elevate I. Quarter 2024 Revenue, this simply has not been enough to rescue LCTC's I. Quarter 2024 performance, Most analysts pointed out.

Within Laboratory Analytical Instruments industry 4 other companies have achieved higher Revenue quarter on quarter growth. While Lifeloc Technologies Inc 's Revenue growth quarter on quarter, overall rank is 1921.


Lifeloc Technologies Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2024)
12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
Cumulative Revenue 12 Months Ending $ 9.32 $ 9.33 $ 9.25 $ 8.59 $ 8.49
Y / Y Revenue Growth (TTM) 9.81 % 9.99 % 15.62 % 9.3 % 14.59 %
Year on Year Revenue Growth Overall Ranking # 878 # 547 # 1021 # 1033 # 812
Seqeuential Revenue Change (TTM) -0.12 % 0.86 % 7.73 % 1.18 % 0.05 %
Seq. Revenue Growth (TTM) Overall Ranking # 1391 # 1240 # 1998 # 1206 # 1703


Cumulative Revenue growth Comment
Assuming the Lifeloc Technologies Inc 's fiscal year would have ended in Mar 31 2024, Lifeloc Technologies Inc would have reprted above average annual Revenue improvement of 9.81% year on year, of $ 9 millions.
This marks a slow-down of the companys growth trends and from the 9.99% growth in Dec 31 2023.

In the Healthcare sector 210 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 547 to 878.

Revenue TTM Q/Q Growth Statistics
High Average Low
23.86 %
2.92 %
-29.35 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 211
Overall # 878

Revenue TTM Y/Y Growth Statistics
High Average Low
23.86 %
2.92 %
-29.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 220
S&P 500 # 1391
Cumulative Revenue growth Comment
Assuming the Lifeloc Technologies Inc 's fiscal year would have ended in Mar 31 2024, Lifeloc Technologies Inc would have reprted above average annual Revenue improvement of 9.81% year on year, of $ 9 millions.
This marks a slow-down of the companys growth trends and from the 9.99% growth in Dec 31 2023.

In the Healthcare sector 210 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 547 to 878.

Revenue TTM Q/Q Growth Statistics
High Average Low
23.86 %
2.92 %
-29.35 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 10
Healthcare Sector # 211
Overall # 878

Revenue TTM Y/Y Growth Statistics
High Average Low
23.86 %
2.92 %
-29.35 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 10
Sector # 220
S&P 500 # 1391




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
LCTC's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for LCTC's Competitors
Revenue Growth for Lifeloc Technologies Inc 's Suppliers
Revenue Growth for LCTC's Customers

You may also want to know
LCTC's Annual Growth Rates LCTC's Profitability Ratios LCTC's Asset Turnover Ratio LCTC's Dividend Growth
LCTC's Roe LCTC's Valuation Ratios LCTC's Financial Strength Ratios LCTC's Dividend Payout Ratio
LCTC's Roa LCTC's Inventory Turnover Ratio LCTC's Growth Rates LCTC's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Mar 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2024
Collegium Pharmaceutical Inc -0.21%$ -0.215 millions
Mettler toledo International Inc -0.30%$ -0.300 millions
3m Company-0.35%$ -0.349 millions
Icu Medical Inc-0.42%$ -0.423 millions
Lifeloc Technologies Inc -0.51%$ -0.513 millions
Regeneron Pharmaceuticals Inc -0.54%$ -0.541 millions
Envista Holdings Corporation-0.62%$ -0.622 millions
Orgenesis Inc-0.70%$ -0.704 millions
T2 Biosystems Inc -0.82%$ -0.818 millions
Vyne Therapeutics Inc -1.01%$ -1.010 millions
Enhabit Inc -1.02%$ -1.018 millions
Ge Healthcare Technologies Inc -1.50%$ -1.502 millions
Baxter International Inc -1.56%$ -1.562 millions
Y mabs Therapeutics inc -1.58%$ -1.580 millions
Pacific Biosciences Of California Inc -1.59%$ -1.589 millions
Cartesian Therapeutics Inc -1.65%$ -1.650 millions
Viatris Inc -1.76%$ -1.762 millions
Sight Sciences Inc -1.87%$ -1.870 millions
Opus Genetics Inc -2.17%$ -2.173 millions
Vaso Corporation-2.51%$ -2.513 millions
Dentsply Sirona Inc -2.56%$ -2.556 millions
Alpha Pro Tech Ltd -2.78%$ -2.775 millions
Prestige Consumer Healthcare Inc -2.82%$ -2.817 millions
West Pharmaceutical Services Inc -2.99%$ -2.986 millions
Wave Life Sciences Ltd -3.02%$ -3.024 millions
Fulgent Genetics Inc -3.12%$ -3.119 millions
Integra Lifesciences Holdings Corp-3.14%$ -3.144 millions
Accelerate Diagnostics Inc -3.17%$ -3.165 millions
National Research Corporation-3.18%$ -3.180 millions
Catheter Precision Inc -3.53%$ -3.529 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com